Metoclopramide. An updated review of its pharmacological properties and clinical use.
Since previously reviewed in the Journal (Vol. 12, No. 2), metoclopramide has been confirmed as an effective drug in treating and preventing various types of vomiting and as a useful agent in oesophageal reflux disease, gastroparesis, dyspepsia, and in a  variety of functional gastrointestinal disorders. Of considerable importance is the recent evidence of its efficacy when administered intravenously in high dosages in preventing severe vomiting associated with cisplatin. Good results have been achieved in patients not previously treated with cisplatin, but further studies are needed to determine its level of efficacy in patients who have experienced severe vomiting during earlier courses of cytotoxic therapy. Side effects consisting of mild sedation, diarrhoea and reversible extrapyramidal reactions have occurred, but are tolerated by many patients.
D000818:Animals; D004347:Drug Interactions; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D007700:Kinetics; D008787:Metoclopramide / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology* / Q000506:poisoning / Q000627:therapeutic use; D014839:Vomiting / Q000188:drug therapy
D008787:Metoclopramide